Malin Corporation plc (MLLNF)
OTCMKTS · Delayed Price · Currency is USD
6.40
+0.20 (3.23%)
At close: Sep 18, 2024
Malin Corporation Market Cap
Malin Corporation has a market cap or net worth of $41.57 million as of August 15, 2025. Its market cap has decreased by -64.68% in one year.
Market Cap
41.57M
Enterprise Value
-31.15M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$6.40
Market Cap Chart
Since March 25, 2015, Malin Corporation's market cap has decreased from 417.22M to 41.57M, a decrease of -90.04%. That is a compound annual growth rate of -19.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 41.57M | -75.28% |
| Dec 31, 2024 | 168.18M | 79.80% |
| Dec 29, 2023 | 93.54M | -64.54% |
| Dec 30, 2022 | 263.77M | -20.31% |
| Dec 30, 2021 | 331.01M | 43.46% |
| Dec 29, 2020 | 230.74M | -1.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 781.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 580.94M |
| Glass House Brands | 567.91M |
| American Oncology Network | 379.23M |
| Northwest Biotherapeutics | 363.17M |
| CytoDyn | 344.75M |